Anesthesia & Pain Management
FDA awards $1.5M grant to ADA Science & Research Institute
August 28, 2020 -- The ADA announced that the U.S. Food and Drug Administration (FDA) has awarded a three-year, $1.5 million grant to the ADA Science & Research Institute in collaboration with the University of Pittsburgh to develop a clinical practice guideline for the management of acute pain in dentistry, with a focus on the role of opioids.
DEA to raise prescriber fee on October 1
August 3, 2020 -- The U.S. Drug Enforcement Administration (DEA) will raise its prescriber registration fee from $731 to $888 on October 1, according to the California Dental Association.
FDA update: Naloxone and opioid labeling changes
July 28, 2020 -- Tom Viola, RPh, explains why dentists may want to know about naloxone and why it is being discussed currently by the U.S. Food and Drug Administration (FDA) in connection with opioid use disorder.  Discuss
What to know about antibiotics and the risk of cardiovascular death
July 9, 2020 -- The relative safety of azithromycin was first questioned following a study published in 2012, which reported an association between azithromycin use and sudden cardiac death. Now Tom Viola, RPh, discusses why the drug is once again making headlines.  Discuss
What every dentist and team member should know about these 2 drugs
July 1, 2020 -- A new U.S. Food and Drug Administration (FDA) warning regarding gabapentin and pregabalin recently caught the eye of Tom Viola, RPh. Now, he has some advice to share with DrBicuspid.com readers on why the warning is something they should understand and heed.  Discuss
UTHSC secures $1.7M for opioid addiction studies
June 8, 2020 -- Researchers from the University of Tennessee Health Science Center (UTHSC) have been awarded $1.7 million from the U.S. National Institutes of Health to study the genetic factors of opioid addiction.
Podcast: Thoughts on pain control and prescriptions after COVID-19's rise
June 5, 2020 -- Tom Viola, RPh, has some advice to share with DrBicuspid.com readers on opioid usage and pain control as dental practices continue to move forward after the COVID-19 pandemic and subsequent disruption.  Discuss
Antipain center discovered in mice may lead to new painkillers
May 21, 2020 -- Scientists have discovered a small area in the brains of mice that dampens their sense of pain, which could eventually lead to new pain management treatments for humans, according to a study published on May 18 in Nature Neuroscience.  Discuss
3-cm swallowed dental needle removed from patient's neck
May 19, 2020 -- Clinicians removed a 3-cm needle from a patient who swallowed it, likely during a dental procedure, according to a recent case report published in the April issue of the Journal of Dental Anesthesia and Pain Medicine.  Discuss
Antibiotics alter how brains of rats react to opioids
May 8, 2020 -- New research shows that antibiotics may change how the gut-brain connection works in rats dependent on opioids. The use of antibiotics altered the way the rats' brains responded to opioid use and withdrawal, according to the findings of a study published on April 27 in ENeuro.  Discuss
Hot Topic
Second Opinion: Outpatient detoxification for opioid-addicted patients

While steps are needed to reduce the number of prescribed opioids in the U.S., what about those patients who may already be addicted and at risk? In this Second Opinion, Vikram Tarugu, MD, details a detoxification program that may be appropriate for your patients and your community. Read more.

Conferences
Parenteral Moderate Sedation Training for Dentists
September 11-27
Houston, Texas United States
Parenteral Moderate Sedation Training for Dentists
October 9-25
Denver, Colorado United States
ACLS Training for Dentists and Staff
October 16
Denver, Colorado United States
Sedation Permit Renewal/Refresher for Dentistry
October 17
Denver, Colorado United States
Parenteral Moderate Sedation Training for Dentists
November 6-23
Dallas, Texas United States